A potential immunotherapy strategy for early-stage prostate cancer

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically “cold,” meaning they do not attract enough immune cells to mount a strong attack. Hormone therapy commonly used for prostate…

Continue Reading

News Source: medicalxpress.com